Literature DB >> 2603358

A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine.

T G Kimman1, J Sol, F Westenbrink, P J Straver.   

Abstract

A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus (BRSV) on a large beef-fattening farm is described. The outbreak started two days after five- to seven-month-old calves were vaccinated with a modified live BRSV vaccine. The disease ran a very severe course among five- to seven-month-old vaccinated calves, but disease was absent in eight-month-old an older non-vaccinated calves. The presence of IgM antibodies in sera of non-vaccinated calves indicated that BRSV was spreading on the farm between two to 15 days before the day of vaccination. The data indicate that vaccination with modified live vaccine during the course of a natural infection may enhance the severity of disease. The possible pathogenesis of the disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2603358     DOI: 10.1080/01652176.1989.9694231

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  17 in total

Review 1.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves.

Authors:  R M Gaddum; R S Cook; L H Thomas; G Taylor
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

3.  Respiratory syncytial virus--how soon will we have a vaccine?

Authors:  G L Toms
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

4.  Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.

Authors:  M Oumouna; J W Mapletoft; B C Karvonen; L A Babiuk; S van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.

Authors:  John A Ellis; Keith H West; Cheryl Waldner; Carrie Rhodes
Journal:  Can Vet J       Date:  2005-02       Impact factor: 1.008

Review 6.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

7.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

8.  Bovine respiratory syncytial virus (BRSV) pneumonia in beef calf herds despite vaccination.

Authors:  L E Larsen; C Tegtmeier; E Pedersen
Journal:  Acta Vet Scand       Date:  2001       Impact factor: 1.695

Review 9.  Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants.

Authors:  Randy E Sacco; Jodi L McGill; Mitchell V Palmer; John D Lippolis; Timothy A Reinhardt; Brian J Nonnecke
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.

Authors:  Krister Blodörn; Sara Hägglund; Jenna Fix; Catherine Dubuquoy; Boby Makabi-Panzu; Michelle Thom; Per Karlsson; Jean-Louis Roque; Erika Karlstam; John Pringle; Jean-François Eléouët; Sabine Riffault; Geraldine Taylor; Jean François Valarcher
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.